Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis

Lee, J[Lee, J.]; Kang, W[Kang, W.]; Lim, D[Lim, D.]; Park, J[Park, J.]; Park, Y[Park, Y.]; Lim, H[Lim, H.]; Sohn, T[Sohn, T.]; Noh, J[Noh, J.]; Bae, J[Bae, J.]; Kim, S[Kim, S.]

Detailed Information

Cited 1 time in webofscience

Cited 0 time in scopus

Metadata Downloads

Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis

Authors: Lee, J[Lee, J.]; Kang, W[Kang, W.]; Lim, D[Lim, D.]; Park, J[Park, J.]; Park, Y[Park, Y.]; Lim, H[Lim, H.]; Sohn, T[Sohn, T.]; Noh, J[Noh, J.]; Bae, J[Bae, J.]; Kim, S[Kim, S.]

Issue Date: 20-May-2009

Publisher: AMER SOC CLINICAL ONCOLOGY

Citation: JOURNAL OF CLINICAL ONCOLOGY, v.27, no.15

Indexed: SCIE
SCOPUS

Journal Title: JOURNAL OF CLINICAL ONCOLOGY

Volume: 27

Number: 15

URI: https://scholarx.skku.edu/handle/2021.sw.skku/77839

ISSN: 0732-183X

Files in This Item: There are no files associated with this item.

Appears in Collections: Medicine > Department of Medicine > 1. Journal Articles

Show full item record

qrcode

Altmetrics

Total Views & Downloads

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Altmetrics

Total Views & Downloads

BROWSE